Streetbeat News

Earnings

LZB

La-Z-Boy CFO Bob Lucian announced Q4 fiscal 2024 sales expectations of $505M-$535M, below the estimated $544.39M, with a Non-GAAP operating margin of 7-8%. This comes after Q3 results met sales guidance and margin expectations, excluding January's weather impacts. The company aims for prudent near-term planning while focusing on long-term investments and growth.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:18 pm

O

Realty Income (NYSE:O) reported its Q4 AFFO per share at $1.01, missing the consensus estimate of $1.04 by 2.88%. However, its quarterly sales of $1.08 billion exceeded expectations by 5.18%, marking a 21.08% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:17 pm

NHI

National Health Investors (NHI) forecasts its FY24 FFO to be in the range of $4.31-$4.37, closely aligning with the estimated $4.33.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:17 pm

CE

Celanese Corporation, identified by its ticker symbol CE, has provided guidance for its Q1 adjusted earnings per share (EPS), projecting a range of $1.75 to $2.00. This forecast falls below the estimated $2.53, indicating a potential downturn in the company's financial performance for the quarter.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:17 pm

SPNT

SiriusPoint (NYSE:SPNT) reported Q4 2023 earnings of $0.50 per share with sales of $645.80M, a 4.13% decrease from $673.60M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:17 pm

AMPL

Amplitude (NASDAQ:AMPL) reported Q4 2023 earnings of $0.04 per share, surpassing the $0.03 estimate, marking a 233.33% increase from last year. However, its sales of $71.40M slightly missed the $71.50M estimate, though they represent a 9.42% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:16 pm

AIP

Arteris (NASDAQ:AIP) reported Q4 2023 adjusted EPS of $(0.18), surpassing the $(0.20) estimate. Sales reached $12.50M, exceeding the $11.84M forecast, marking an 11.61% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:16 pm

CE

Celanese (NYSE:CE) reported Q4 2023 adjusted EPS of $2.24, missing the $2.31 estimate, and sales of $2.57B, below the $2.59B estimate. This represents a 9.41% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:16 pm

LZB

La-Z-Boy reported Q3 earnings of $0.67 per share, missing the consensus estimate of $0.72, and sales of $500.41M, missing the estimate of $523.09M. This represents a decrease in earnings and sales from the same period last year.

Portfolio Pulse from Happy Mohamed

February 20, 2024 | 9:16 pm

NHI

National Health Investors (NHI) reported Q4 2023 earnings of $1.09 per share, surpassing the $1.07 estimate. Sales reached $79.47M, exceeding the $78.44M forecast, marking a 12.45% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 9:16 pm